Ann: Phase 2 SAMDE Study Update, page-3

Going really well here. Having sensitivity that is 50% greater than the existing treatment (Current standard of care 49%, TRI preliminary result 71.6%) is very encouraging. Being an adaptive algorithm means this will only get better as the trailing goes on.

A step change better than the current standard of care puts the company in a position to engage further with the existing sleep centres it has engaged for the trials.

This quote makes me particularly positive in terms of the commercialisation pathway;
Additional centre added following high level of in-bound enquiries from industry
participants.